nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—gestational diabetes—type 2 diabetes mellitus	0.14	1	CtDrD
Glyburide—Sulfonylurea Compounds—Chlorpropamide—type 2 diabetes mellitus	0.0504	0.2	CiPCiCtD
Glyburide—Sulfonylurea Compounds—Tolazamide—type 2 diabetes mellitus	0.0504	0.2	CiPCiCtD
Glyburide—Sulfonylurea Compounds—Glipizide—type 2 diabetes mellitus	0.0504	0.2	CiPCiCtD
Glyburide—Sulfonylurea Compounds—Tolbutamide—type 2 diabetes mellitus	0.0504	0.2	CiPCiCtD
Glyburide—Sulfonylurea Compounds—Glimepiride—type 2 diabetes mellitus	0.0504	0.2	CiPCiCtD
Glyburide—Tolazamide—type 2 diabetes mellitus	0.0404	0.21	CrCtD
Glyburide—Glimepiride—type 2 diabetes mellitus	0.0404	0.21	CrCtD
Glyburide—Gliclazide—type 2 diabetes mellitus	0.0383	0.199	CrCtD
Glyburide—Glipizide—type 2 diabetes mellitus	0.0383	0.199	CrCtD
Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.035	0.182	CrCtD
Glyburide—CPT1A—type 2 diabetes mellitus	0.0349	0.375	CbGaD
Glyburide—ABCC8—type 2 diabetes mellitus	0.0242	0.26	CbGaD
Glyburide—KCNJ11—type 2 diabetes mellitus	0.0171	0.183	CbGaD
Glyburide—KCNJ1—Tolazamide—type 2 diabetes mellitus	0.0115	0.088	CbGbCtD
Glyburide—KCNJ1—Glimepiride—type 2 diabetes mellitus	0.0102	0.0785	CbGbCtD
Glyburide—ABCC2—type 2 diabetes mellitus	0.00923	0.0991	CbGaD
Glyburide—Gliquidone—Glimepiride—type 2 diabetes mellitus	0.00737	0.0572	CrCrCtD
Glyburide—Gliquidone—Glipizide—type 2 diabetes mellitus	0.00699	0.0543	CrCrCtD
Glyburide—KCNJ1—Tolbutamide—type 2 diabetes mellitus	0.00659	0.0506	CbGbCtD
Glyburide—ABCC8—Tolazamide—type 2 diabetes mellitus	0.00624	0.0479	CbGbCtD
Glyburide—ABCC8—Glimepiride—type 2 diabetes mellitus	0.00556	0.0426	CbGbCtD
Glyburide—KCNJ11—Tolazamide—type 2 diabetes mellitus	0.00539	0.0414	CbGbCtD
Glyburide—ABCC8—Glipizide—type 2 diabetes mellitus	0.00508	0.039	CbGbCtD
Glyburide—KCNJ11—Glimepiride—type 2 diabetes mellitus	0.0048	0.0369	CbGbCtD
Glyburide—ABCC8—Gliclazide—type 2 diabetes mellitus	0.00473	0.0363	CbGbCtD
Glyburide—Glimepiride—Tolbutamide—type 2 diabetes mellitus	0.00447	0.0347	CrCrCtD
Glyburide—Glimepiride—Glipizide—type 2 diabetes mellitus	0.00447	0.0347	CrCrCtD
Glyburide—Tolazamide—Gliclazide—type 2 diabetes mellitus	0.00447	0.0347	CrCrCtD
Glyburide—Tolazamide—Tolbutamide—type 2 diabetes mellitus	0.00447	0.0347	CrCrCtD
Glyburide—Tolazamide—Glipizide—type 2 diabetes mellitus	0.00447	0.0347	CrCrCtD
Glyburide—Glimepiride—Gliclazide—type 2 diabetes mellitus	0.00447	0.0347	CrCrCtD
Glyburide—ABCC8—Repaglinide—type 2 diabetes mellitus	0.00444	0.0341	CbGbCtD
Glyburide—KCNJ11—Glipizide—type 2 diabetes mellitus	0.00439	0.0337	CbGbCtD
Glyburide—Gliclazide—Glimepiride—type 2 diabetes mellitus	0.00423	0.0329	CrCrCtD
Glyburide—Gliclazide—Tolazamide—type 2 diabetes mellitus	0.00423	0.0329	CrCrCtD
Glyburide—Glipizide—Glimepiride—type 2 diabetes mellitus	0.00423	0.0329	CrCrCtD
Glyburide—Glipizide—Tolazamide—type 2 diabetes mellitus	0.00423	0.0329	CrCrCtD
Glyburide—KCNJ11—Gliclazide—type 2 diabetes mellitus	0.00409	0.0313	CbGbCtD
Glyburide—Glimepiride—Chlorpropamide—type 2 diabetes mellitus	0.00408	0.0317	CrCrCtD
Glyburide—Tolazamide—Chlorpropamide—type 2 diabetes mellitus	0.00408	0.0317	CrCrCtD
Glyburide—CYP3A4—type 2 diabetes mellitus	0.00408	0.0438	CbGaD
Glyburide—ABCC8—Chlorpropamide—type 2 diabetes mellitus	0.00402	0.0308	CbGbCtD
Glyburide—Glipizide—Gliclazide—type 2 diabetes mellitus	0.00401	0.0312	CrCrCtD
Glyburide—Gliclazide—Tolbutamide—type 2 diabetes mellitus	0.00401	0.0312	CrCrCtD
Glyburide—Gliclazide—Glipizide—type 2 diabetes mellitus	0.00401	0.0312	CrCrCtD
Glyburide—Glipizide—Tolbutamide—type 2 diabetes mellitus	0.00401	0.0312	CrCrCtD
Glyburide—Glisoxepide—Glimepiride—type 2 diabetes mellitus	0.00385	0.0299	CrCrCtD
Glyburide—Glisoxepide—Tolazamide—type 2 diabetes mellitus	0.00385	0.0299	CrCrCtD
Glyburide—KCNJ11—Repaglinide—type 2 diabetes mellitus	0.00384	0.0295	CbGbCtD
Glyburide—Gliclazide—Chlorpropamide—type 2 diabetes mellitus	0.00367	0.0285	CrCrCtD
Glyburide—Glipizide—Chlorpropamide—type 2 diabetes mellitus	0.00367	0.0285	CrCrCtD
Glyburide—Glisoxepide—Gliclazide—type 2 diabetes mellitus	0.00365	0.0284	CrCrCtD
Glyburide—Glisoxepide—Glipizide—type 2 diabetes mellitus	0.00365	0.0284	CrCrCtD
Glyburide—Glisoxepide—Tolbutamide—type 2 diabetes mellitus	0.00365	0.0284	CrCrCtD
Glyburide—ABCC8—Tolbutamide—type 2 diabetes mellitus	0.00358	0.0275	CbGbCtD
Glyburide—ALB—type 2 diabetes mellitus	0.00356	0.0382	CbGaD
Glyburide—Chlorpropamide—Tolazamide—type 2 diabetes mellitus	0.00354	0.0275	CrCrCtD
Glyburide—Chlorpropamide—Glimepiride—type 2 diabetes mellitus	0.00354	0.0275	CrCrCtD
Glyburide—KCNJ11—Chlorpropamide—type 2 diabetes mellitus	0.00347	0.0266	CbGbCtD
Glyburide—Chlorpropamide—Tolbutamide—type 2 diabetes mellitus	0.00336	0.0261	CrCrCtD
Glyburide—Chlorpropamide—Glipizide—type 2 diabetes mellitus	0.00336	0.0261	CrCrCtD
Glyburide—Chlorpropamide—Gliclazide—type 2 diabetes mellitus	0.00336	0.0261	CrCrCtD
Glyburide—Glisoxepide—Chlorpropamide—type 2 diabetes mellitus	0.00334	0.0259	CrCrCtD
Glyburide—KCNJ11—Tolbutamide—type 2 diabetes mellitus	0.0031	0.0238	CbGbCtD
Glyburide—ABCC8—Nateglinide—type 2 diabetes mellitus	0.00305	0.0234	CbGbCtD
Glyburide—KCNJ11—Nateglinide—type 2 diabetes mellitus	0.00263	0.0202	CbGbCtD
Glyburide—SLCO2B1—Tolbutamide—type 2 diabetes mellitus	0.00238	0.0183	CbGbCtD
Glyburide—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.00187	0.0144	CbGbCtD
Glyburide—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.00167	0.0128	CbGbCtD
Glyburide—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.00161	0.0124	CbGbCtD
Glyburide—SLC15A2—Ramipril—type 2 diabetes mellitus	0.00149	0.0114	CbGbCtD
Glyburide—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.00144	0.011	CbGbCtD
Glyburide—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.00142	0.0109	CbGbCtD
Glyburide—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0013	0.01	CbGbCtD
Glyburide—SLC15A1—Ramipril—type 2 diabetes mellitus	0.00128	0.00982	CbGbCtD
Glyburide—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.00122	0.00937	CbGbCtD
Glyburide—ALB—Gliclazide—type 2 diabetes mellitus	0.00089	0.00683	CbGbCtD
Glyburide—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.000888	0.00681	CbGbCtD
Glyburide—ALB—Repaglinide—type 2 diabetes mellitus	0.000836	0.00642	CbGbCtD
Glyburide—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.000792	0.00607	CbGbCtD
Glyburide—ALB—Rosiglitazone—type 2 diabetes mellitus	0.000698	0.00536	CbGbCtD
Glyburide—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.000673	0.00516	CbGbCtD
Glyburide—ALB—Valsartan—type 2 diabetes mellitus	0.000617	0.00473	CbGbCtD
Glyburide—ABCB1—Linagliptin—type 2 diabetes mellitus	0.000614	0.00471	CbGbCtD
Glyburide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.000577	0.00442	CbGbCtD
Glyburide—ALB—Nateglinide—type 2 diabetes mellitus	0.000573	0.0044	CbGbCtD
Glyburide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.000564	0.00433	CbGbCtD
Glyburide—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.000547	0.0042	CbGbCtD
Glyburide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.000516	0.00396	CbGbCtD
Glyburide—ABCC8—penis—type 2 diabetes mellitus	0.000506	0.0721	CbGeAlD
Glyburide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00049	0.00376	CbGbCtD
Glyburide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00049	0.00376	CbGbCtD
Glyburide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.000479	0.00368	CbGbCtD
Glyburide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.000453	0.00347	CbGbCtD
Glyburide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.000437	0.00335	CbGbCtD
Glyburide—SLC22A6—Losartan—type 2 diabetes mellitus	0.000416	0.00319	CbGbCtD
Glyburide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.000408	0.00313	CbGbCtD
Glyburide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.000408	0.00313	CbGbCtD
Glyburide—ABCA1—artery—type 2 diabetes mellitus	0.000399	0.0568	CbGeAlD
Glyburide—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.000396	0.00304	CbGbCtD
Glyburide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.000376	0.00289	CbGbCtD
Glyburide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.000368	0.00282	CbGbCtD
Glyburide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.000363	0.00279	CbGbCtD
Glyburide—ALB—Losartan—type 2 diabetes mellitus	0.000354	0.00272	CbGbCtD
Glyburide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.000332	0.00255	CbGbCtD
Glyburide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.000328	0.00252	CbGbCtD
Glyburide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.000309	0.00237	CbGbCtD
Glyburide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0003	0.0023	CbGbCtD
Glyburide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.000296	0.00227	CbGbCtD
Glyburide—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.000272	0.00209	CbGbCtD
Glyburide—KCNJ5—cardiovascular system—type 2 diabetes mellitus	0.00027	0.0384	CbGeAlD
Glyburide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.000262	0.00201	CbGbCtD
Glyburide—KCNJ5—pancreas—type 2 diabetes mellitus	0.000262	0.0373	CbGeAlD
Glyburide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.000237	0.00182	CbGbCtD
Glyburide—CYP2C19—Losartan—type 2 diabetes mellitus	0.00023	0.00176	CbGbCtD
Glyburide—CPT1A—islet of Langerhans—type 2 diabetes mellitus	0.000206	0.0293	CbGeAlD
Glyburide—ABCC9—cardiovascular system—type 2 diabetes mellitus	0.000204	0.0291	CbGeAlD
Glyburide—CYP2C9—Losartan—type 2 diabetes mellitus	0.000191	0.00146	CbGbCtD
Glyburide—ABCB1—Losartan—type 2 diabetes mellitus	0.000185	0.00142	CbGbCtD
Glyburide—CFTR—islet of Langerhans—type 2 diabetes mellitus	0.000181	0.0258	CbGeAlD
Glyburide—ABCC9—adipose tissue—type 2 diabetes mellitus	0.00018	0.0257	CbGeAlD
Glyburide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00018	0.00138	CbGbCtD
Glyburide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.000172	0.00132	CbGbCtD
Glyburide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.000172	0.00132	CbGbCtD
Glyburide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00125	CbGbCtD
Glyburide—KCNJ1—nephron tubule—type 2 diabetes mellitus	0.000162	0.0231	CbGeAlD
Glyburide—CPT1A—cardiovascular system—type 2 diabetes mellitus	0.000149	0.0212	CbGeAlD
Glyburide—CPT1A—kidney—type 2 diabetes mellitus	0.000145	0.0207	CbGeAlD
Glyburide—CPT1A—pancreas—type 2 diabetes mellitus	0.000145	0.0206	CbGeAlD
Glyburide—KCNJ1—kidney—type 2 diabetes mellitus	0.000142	0.0203	CbGeAlD
Glyburide—KCNJ1—cortex of kidney—type 2 diabetes mellitus	0.000139	0.0198	CbGeAlD
Glyburide—ABCA1—cardiovascular system—type 2 diabetes mellitus	0.000139	0.0197	CbGeAlD
Glyburide—ABCA1—kidney—type 2 diabetes mellitus	0.000136	0.0193	CbGeAlD
Glyburide—CPT1A—adipose tissue—type 2 diabetes mellitus	0.000131	0.0187	CbGeAlD
Glyburide—CFTR—kidney—type 2 diabetes mellitus	0.000128	0.0182	CbGeAlD
Glyburide—CFTR—pancreas—type 2 diabetes mellitus	0.000127	0.0181	CbGeAlD
Glyburide—ABCC9—liver—type 2 diabetes mellitus	0.000126	0.018	CbGeAlD
Glyburide—ABCA1—adipose tissue—type 2 diabetes mellitus	0.000122	0.0174	CbGeAlD
Glyburide—KCNJ11—islet of Langerhans—type 2 diabetes mellitus	0.000122	0.0174	CbGeAlD
Glyburide—ABCC8—islet of Langerhans—type 2 diabetes mellitus	0.000112	0.016	CbGeAlD
Glyburide—CYP3A4—Losartan—type 2 diabetes mellitus	0.000111	0.000852	CbGbCtD
Glyburide—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000104	0.0148	CbGeAlD
Glyburide—SLC22A7—kidney—type 2 diabetes mellitus	9.47e-05	0.0135	CbGeAlD
Glyburide—Gliquidone—ABCC8—type 2 diabetes mellitus	9.24e-05	0.0952	CrCbGaD
Glyburide—SLC22A7—cortex of kidney—type 2 diabetes mellitus	9.22e-05	0.0131	CbGeAlD
Glyburide—CPT1A—liver—type 2 diabetes mellitus	9.2e-05	0.0131	CbGeAlD
Glyburide—SLC22A6—cortex of kidney—type 2 diabetes mellitus	8.9e-05	0.0127	CbGeAlD
Glyburide—KCNJ11—cardiovascular system—type 2 diabetes mellitus	8.83e-05	0.0126	CbGeAlD
Glyburide—SLC15A1—nephron tubule—type 2 diabetes mellitus	8.66e-05	0.0123	CbGeAlD
Glyburide—KCNJ11—pancreas—type 2 diabetes mellitus	8.58e-05	0.0122	CbGeAlD
Glyburide—ABCA1—liver—type 2 diabetes mellitus	8.57e-05	0.0122	CbGeAlD
Glyburide—ABCC8—cardiovascular system—type 2 diabetes mellitus	8.14e-05	0.0116	CbGeAlD
Glyburide—CFTR—liver—type 2 diabetes mellitus	8.09e-05	0.0115	CbGeAlD
Glyburide—ABCC8—kidney—type 2 diabetes mellitus	7.96e-05	0.0113	CbGeAlD
Glyburide—ABCC8—pancreas—type 2 diabetes mellitus	7.91e-05	0.0113	CbGeAlD
Glyburide—SLC15A1—kidney—type 2 diabetes mellitus	7.61e-05	0.0108	CbGeAlD
Glyburide—Tolazamide—ABCC8—type 2 diabetes mellitus	7.39e-05	0.0761	CrCbGaD
Glyburide—ABCC3—kidney—type 2 diabetes mellitus	6.68e-05	0.00952	CbGeAlD
Glyburide—Glisoxepide—ABCC8—type 2 diabetes mellitus	6.68e-05	0.0688	CrCbGaD
Glyburide—ABCB11—liver—type 2 diabetes mellitus	6.64e-05	0.00946	CbGeAlD
Glyburide—Glimepiride—ABCC8—type 2 diabetes mellitus	6.58e-05	0.0678	CrCbGaD
Glyburide—Gliquidone—KCNJ11—type 2 diabetes mellitus	6.51e-05	0.0671	CrCbGaD
Glyburide—SLCO2B1—kidney—type 2 diabetes mellitus	6.23e-05	0.00888	CbGeAlD
Glyburide—ABCC2—nephron tubule—type 2 diabetes mellitus	6.08e-05	0.00866	CbGeAlD
Glyburide—ABCC3—adipose tissue—type 2 diabetes mellitus	6.02e-05	0.00858	CbGeAlD
Glyburide—SLC22A7—liver—type 2 diabetes mellitus	5.99e-05	0.00853	CbGeAlD
Glyburide—SLC15A2—retina—type 2 diabetes mellitus	5.75e-05	0.00819	CbGeAlD
Glyburide—SLCO1A2—kidney—type 2 diabetes mellitus	5.73e-05	0.00817	CbGeAlD
Glyburide—Glipizide—ABCC8—type 2 diabetes mellitus	5.71e-05	0.0588	CrCbGaD
Glyburide—SLCO2B1—adipose tissue—type 2 diabetes mellitus	5.61e-05	0.008	CbGeAlD
Glyburide—SLC15A2—nephron tubule—type 2 diabetes mellitus	5.41e-05	0.00771	CbGeAlD
Glyburide—ABCC2—kidney—type 2 diabetes mellitus	5.34e-05	0.00761	CbGeAlD
Glyburide—Gliclazide—ABCC8—type 2 diabetes mellitus	5.31e-05	0.0547	CrCbGaD
Glyburide—Tolazamide—KCNJ11—type 2 diabetes mellitus	5.2e-05	0.0536	CrCbGaD
Glyburide—ABCC2—cortex of kidney—type 2 diabetes mellitus	5.2e-05	0.00741	CbGeAlD
Glyburide—SLC15A1—liver—type 2 diabetes mellitus	4.81e-05	0.00685	CbGeAlD
Glyburide—SLC15A2—kidney—type 2 diabetes mellitus	4.76e-05	0.00678	CbGeAlD
Glyburide—Glisoxepide—KCNJ11—type 2 diabetes mellitus	4.71e-05	0.0485	CrCbGaD
Glyburide—Glimepiride—KCNJ11—type 2 diabetes mellitus	4.64e-05	0.0478	CrCbGaD
Glyburide—SLC15A2—cortex of kidney—type 2 diabetes mellitus	4.63e-05	0.0066	CbGeAlD
Glyburide—ABCC1—cortex of kidney—type 2 diabetes mellitus	4.58e-05	0.00653	CbGeAlD
Glyburide—ABCG2—nephron tubule—type 2 diabetes mellitus	4.43e-05	0.00632	CbGeAlD
Glyburide—ABCC1—adipose tissue—type 2 diabetes mellitus	4.24e-05	0.00604	CbGeAlD
Glyburide—ABCC3—liver—type 2 diabetes mellitus	4.22e-05	0.00602	CbGeAlD
Glyburide—Chlorpropamide—ABCC8—type 2 diabetes mellitus	4.13e-05	0.0425	CrCbGaD
Glyburide—Glipizide—KCNJ11—type 2 diabetes mellitus	4.02e-05	0.0414	CrCbGaD
Glyburide—SLCO2B1—liver—type 2 diabetes mellitus	3.94e-05	0.00561	CbGeAlD
Glyburide—Gliclazide—KCNJ11—type 2 diabetes mellitus	3.74e-05	0.0385	CrCbGaD
Glyburide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	3.64e-05	0.00518	CbGeAlD
Glyburide—SLCO1A2—liver—type 2 diabetes mellitus	3.62e-05	0.00516	CbGeAlD
Glyburide—ALB—liver—type 2 diabetes mellitus	3.6e-05	0.00513	CbGeAlD
Glyburide—ABCG2—adipose tissue—type 2 diabetes mellitus	3.51e-05	0.005	CbGeAlD
Glyburide—Bezafibrate—HMGCR—type 2 diabetes mellitus	3.45e-05	0.0355	CrCbGaD
Glyburide—Bezafibrate—PPARA—type 2 diabetes mellitus	3.39e-05	0.035	CrCbGaD
Glyburide—ABCC2—liver—type 2 diabetes mellitus	3.38e-05	0.00481	CbGeAlD
Glyburide—ABCC1—liver—type 2 diabetes mellitus	2.97e-05	0.00424	CbGeAlD
Glyburide—Chlorpropamide—KCNJ11—type 2 diabetes mellitus	2.91e-05	0.03	CrCbGaD
Glyburide—CYP2C19—liver—type 2 diabetes mellitus	2.9e-05	0.00413	CbGeAlD
Glyburide—Gliclazide—VEGFA—type 2 diabetes mellitus	2.9e-05	0.0299	CrCbGaD
Glyburide—ABCB1—islet of Langerhans—type 2 diabetes mellitus	2.71e-05	0.00387	CbGeAlD
Glyburide—CYP3A4—kidney—type 2 diabetes mellitus	2.71e-05	0.00387	CbGeAlD
Glyburide—ABCG2—liver—type 2 diabetes mellitus	2.46e-05	0.00351	CbGeAlD
Glyburide—ABCB1—retina—type 2 diabetes mellitus	2.32e-05	0.00331	CbGeAlD
Glyburide—CYP2C9—liver—type 2 diabetes mellitus	2.25e-05	0.0032	CbGeAlD
Glyburide—Glipizide—PPARG—type 2 diabetes mellitus	2.23e-05	0.023	CrCbGaD
Glyburide—ABCB1—nephron tubule—type 2 diabetes mellitus	2.19e-05	0.00311	CbGeAlD
Glyburide—ABCB1—cardiovascular system—type 2 diabetes mellitus	1.96e-05	0.0028	CbGeAlD
Glyburide—ABCB1—kidney—type 2 diabetes mellitus	1.92e-05	0.00274	CbGeAlD
Glyburide—ABCB1—pancreas—type 2 diabetes mellitus	1.91e-05	0.00272	CbGeAlD
Glyburide—ABCB1—cortex of kidney—type 2 diabetes mellitus	1.87e-05	0.00267	CbGeAlD
Glyburide—ABCB1—adipose tissue—type 2 diabetes mellitus	1.73e-05	0.00247	CbGeAlD
Glyburide—CYP3A4—liver—type 2 diabetes mellitus	1.71e-05	0.00244	CbGeAlD
Glyburide—Zafirlukast—CYP2E1—type 2 diabetes mellitus	1.65e-05	0.017	CrCbGaD
Glyburide—Bezafibrate—PPARG—type 2 diabetes mellitus	1.63e-05	0.0167	CrCbGaD
Glyburide—Zafirlukast—CYP1A2—type 2 diabetes mellitus	1.57e-05	0.0162	CrCbGaD
Glyburide—ABCB1—liver—type 2 diabetes mellitus	1.21e-05	0.00173	CbGeAlD
Glyburide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	1.19e-05	0.000349	CcSEcCtD
Glyburide—Angioedema—Orlistat—type 2 diabetes mellitus	1.19e-05	0.000347	CcSEcCtD
Glyburide—Confusional state—Gliclazide—type 2 diabetes mellitus	1.18e-05	0.000345	CcSEcCtD
Glyburide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	1.17e-05	0.000343	CcSEcCtD
Glyburide—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	1.16e-05	0.00034	CcSEcCtD
Glyburide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	1.16e-05	0.00034	CcSEcCtD
Glyburide—Asthenia—Pioglitazone—type 2 diabetes mellitus	1.16e-05	0.00034	CcSEcCtD
Glyburide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	1.16e-05	0.000339	CcSEcCtD
Glyburide—Diarrhoea—Glipizide—type 2 diabetes mellitus	1.16e-05	0.000338	CcSEcCtD
Glyburide—Nausea—Rosiglitazone—type 2 diabetes mellitus	1.15e-05	0.000336	CcSEcCtD
Glyburide—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	1.15e-05	0.000335	CcSEcCtD
Glyburide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	1.14e-05	0.000335	CcSEcCtD
Glyburide—Jaundice—Ramipril—type 2 diabetes mellitus	1.14e-05	0.000333	CcSEcCtD
Glyburide—Asthenia—Glimepiride—type 2 diabetes mellitus	1.13e-05	0.000331	CcSEcCtD
Glyburide—Urticaria—Bromocriptine—type 2 diabetes mellitus	1.13e-05	0.000331	CcSEcCtD
Glyburide—Malnutrition—Irbesartan—type 2 diabetes mellitus	1.13e-05	0.000331	CcSEcCtD
Glyburide—Erythema—Irbesartan—type 2 diabetes mellitus	1.13e-05	0.000331	CcSEcCtD
Glyburide—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	1.13e-05	0.00033	CcSEcCtD
Glyburide—Vision blurred—Metformin—type 2 diabetes mellitus	1.13e-05	0.00033	CcSEcCtD
Glyburide—Asthenia—Sitagliptin—type 2 diabetes mellitus	1.13e-05	0.00033	CcSEcCtD
Glyburide—Convulsion—Orlistat—type 2 diabetes mellitus	1.13e-05	0.000329	CcSEcCtD
Glyburide—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	1.13e-05	0.000329	CcSEcCtD
Glyburide—Tremor—Metformin—type 2 diabetes mellitus	1.12e-05	0.000328	CcSEcCtD
Glyburide—Myalgia—Valsartan—type 2 diabetes mellitus	1.12e-05	0.000327	CcSEcCtD
Glyburide—Arthralgia—Valsartan—type 2 diabetes mellitus	1.12e-05	0.000327	CcSEcCtD
Glyburide—Pruritus—Glimepiride—type 2 diabetes mellitus	1.12e-05	0.000326	CcSEcCtD
Glyburide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	1.11e-05	0.000324	CcSEcCtD
Glyburide—Myalgia—Orlistat—type 2 diabetes mellitus	1.11e-05	0.000324	CcSEcCtD
Glyburide—Hypotension—Gliclazide—type 2 diabetes mellitus	1.09e-05	0.000319	CcSEcCtD
Glyburide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	1.09e-05	0.000319	CcSEcCtD
Glyburide—Alopecia—Losartan—type 2 diabetes mellitus	1.08e-05	0.000316	CcSEcCtD
Glyburide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	1.08e-05	0.000316	CcSEcCtD
Glyburide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	1.08e-05	0.000315	CcSEcCtD
Glyburide—Vomiting—Glipizide—type 2 diabetes mellitus	1.08e-05	0.000314	CcSEcCtD
Glyburide—Oedema—Valsartan—type 2 diabetes mellitus	1.07e-05	0.000314	CcSEcCtD
Glyburide—Rash—Glipizide—type 2 diabetes mellitus	1.07e-05	0.000312	CcSEcCtD
Glyburide—Vision blurred—Irbesartan—type 2 diabetes mellitus	1.07e-05	0.000312	CcSEcCtD
Glyburide—Dermatitis—Glipizide—type 2 diabetes mellitus	1.07e-05	0.000311	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	1.07e-05	0.000311	CcSEcCtD
Glyburide—Erythema—Losartan—type 2 diabetes mellitus	1.06e-05	0.000311	CcSEcCtD
Glyburide—Oedema—Orlistat—type 2 diabetes mellitus	1.06e-05	0.00031	CcSEcCtD
Glyburide—Headache—Glipizide—type 2 diabetes mellitus	1.06e-05	0.00031	CcSEcCtD
Glyburide—Tremor—Irbesartan—type 2 diabetes mellitus	1.06e-05	0.00031	CcSEcCtD
Glyburide—Shock—Valsartan—type 2 diabetes mellitus	1.06e-05	0.000309	CcSEcCtD
Glyburide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	1.05e-05	0.000308	CcSEcCtD
Glyburide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	1.05e-05	0.000307	CcSEcCtD
Glyburide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	1.05e-05	0.000307	CcSEcCtD
Glyburide—Hepatitis—Ramipril—type 2 diabetes mellitus	1.05e-05	0.000306	CcSEcCtD
Glyburide—Anaemia—Irbesartan—type 2 diabetes mellitus	1.05e-05	0.000306	CcSEcCtD
Glyburide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	1.04e-05	0.000305	CcSEcCtD
Glyburide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	1.04e-05	0.000304	CcSEcCtD
Glyburide—Zafirlukast—CYP3A4—type 2 diabetes mellitus	1.04e-05	0.0107	CrCbGaD
Glyburide—Angioedema—Irbesartan—type 2 diabetes mellitus	1.03e-05	0.000302	CcSEcCtD
Glyburide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	1.03e-05	0.000301	CcSEcCtD
Glyburide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	1.03e-05	0.0003	CcSEcCtD
Glyburide—Anorexia—Valsartan—type 2 diabetes mellitus	1.02e-05	0.000299	CcSEcCtD
Glyburide—Asthenia—Bromocriptine—type 2 diabetes mellitus	1.02e-05	0.000299	CcSEcCtD
Glyburide—Myalgia—Metformin—type 2 diabetes mellitus	1.02e-05	0.000298	CcSEcCtD
Glyburide—Headache—Pioglitazone—type 2 diabetes mellitus	1.02e-05	0.000297	CcSEcCtD
Glyburide—Leukopenia—Irbesartan—type 2 diabetes mellitus	1.01e-05	0.000296	CcSEcCtD
Glyburide—Visual impairment—Ramipril—type 2 diabetes mellitus	1.01e-05	0.000295	CcSEcCtD
Glyburide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	1.01e-05	0.000295	CcSEcCtD
Glyburide—Nausea—Glipizide—type 2 diabetes mellitus	1.01e-05	0.000294	CcSEcCtD
Glyburide—Vomiting—Glimepiride—type 2 diabetes mellitus	1e-05	0.000293	CcSEcCtD
Glyburide—Hypotension—Valsartan—type 2 diabetes mellitus	1e-05	0.000293	CcSEcCtD
Glyburide—Vision blurred—Losartan—type 2 diabetes mellitus	1e-05	0.000293	CcSEcCtD
Glyburide—Vomiting—Sitagliptin—type 2 diabetes mellitus	1e-05	0.000292	CcSEcCtD
Glyburide—Tremor—Losartan—type 2 diabetes mellitus	9.97e-06	0.000291	CcSEcCtD
Glyburide—Rash—Glimepiride—type 2 diabetes mellitus	9.96e-06	0.000291	CcSEcCtD
Glyburide—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.95e-06	0.000291	CcSEcCtD
Glyburide—Rash—Sitagliptin—type 2 diabetes mellitus	9.93e-06	0.00029	CcSEcCtD
Glyburide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.92e-06	0.00029	CcSEcCtD
Glyburide—Headache—Glimepiride—type 2 diabetes mellitus	9.89e-06	0.000289	CcSEcCtD
Glyburide—Headache—Sitagliptin—type 2 diabetes mellitus	9.86e-06	0.000288	CcSEcCtD
Glyburide—Anaemia—Losartan—type 2 diabetes mellitus	9.84e-06	0.000288	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.79e-06	0.000286	CcSEcCtD
Glyburide—Oedema—Metformin—type 2 diabetes mellitus	9.78e-06	0.000286	CcSEcCtD
Glyburide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.75e-06	0.000285	CcSEcCtD
Glyburide—Angioedema—Losartan—type 2 diabetes mellitus	9.73e-06	0.000284	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.67e-06	0.000283	CcSEcCtD
Glyburide—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.65e-06	0.000282	CcSEcCtD
Glyburide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.64e-06	0.000282	CcSEcCtD
Glyburide—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.63e-06	0.000281	CcSEcCtD
Glyburide—Myalgia—Irbesartan—type 2 diabetes mellitus	9.63e-06	0.000281	CcSEcCtD
Glyburide—Shock—Metformin—type 2 diabetes mellitus	9.63e-06	0.000281	CcSEcCtD
Glyburide—Glipizide—CYP3A4—type 2 diabetes mellitus	9.61e-06	0.0099	CrCbGaD
Glyburide—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.59e-06	0.00028	CcSEcCtD
Glyburide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.58e-06	0.00028	CcSEcCtD
Glyburide—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.58e-06	0.00028	CcSEcCtD
Glyburide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.56e-06	0.000279	CcSEcCtD
Glyburide—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.53e-06	0.000279	CcSEcCtD
Glyburide—Leukopenia—Losartan—type 2 diabetes mellitus	9.53e-06	0.000278	CcSEcCtD
Glyburide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.46e-06	0.000276	CcSEcCtD
Glyburide—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.46e-06	0.000276	CcSEcCtD
Glyburide—Nausea—Glimepiride—type 2 diabetes mellitus	9.38e-06	0.000274	CcSEcCtD
Glyburide—Nausea—Sitagliptin—type 2 diabetes mellitus	9.35e-06	0.000273	CcSEcCtD
Glyburide—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.34e-06	0.000273	CcSEcCtD
Glyburide—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.34e-06	0.000273	CcSEcCtD
Glyburide—Anorexia—Metformin—type 2 diabetes mellitus	9.33e-06	0.000273	CcSEcCtD
Glyburide—Urticaria—Gliclazide—type 2 diabetes mellitus	9.29e-06	0.000271	CcSEcCtD
Glyburide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.28e-06	0.000271	CcSEcCtD
Glyburide—Alopecia—Ramipril—type 2 diabetes mellitus	9.27e-06	0.000271	CcSEcCtD
Glyburide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.24e-06	0.00027	CcSEcCtD
Glyburide—Oedema—Irbesartan—type 2 diabetes mellitus	9.23e-06	0.00027	CcSEcCtD
Glyburide—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.23e-06	0.00027	CcSEcCtD
Glyburide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.17e-06	0.000268	CcSEcCtD
Glyburide—Hypotension—Metformin—type 2 diabetes mellitus	9.14e-06	0.000267	CcSEcCtD
Glyburide—Malnutrition—Ramipril—type 2 diabetes mellitus	9.13e-06	0.000267	CcSEcCtD
Glyburide—Erythema—Ramipril—type 2 diabetes mellitus	9.13e-06	0.000267	CcSEcCtD
Glyburide—Shock—Irbesartan—type 2 diabetes mellitus	9.08e-06	0.000265	CcSEcCtD
Glyburide—Arthralgia—Losartan—type 2 diabetes mellitus	9.06e-06	0.000265	CcSEcCtD
Glyburide—Myalgia—Losartan—type 2 diabetes mellitus	9.06e-06	0.000265	CcSEcCtD
Glyburide—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.06e-06	0.000265	CcSEcCtD
Glyburide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.05e-06	0.000265	CcSEcCtD
Glyburide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.04e-06	0.000264	CcSEcCtD
Glyburide—Rash—Bromocriptine—type 2 diabetes mellitus	8.98e-06	0.000262	CcSEcCtD
Glyburide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.97e-06	0.000262	CcSEcCtD
Glyburide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.93e-06	0.000261	CcSEcCtD
Glyburide—Headache—Bromocriptine—type 2 diabetes mellitus	8.92e-06	0.000261	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.91e-06	0.00026	CcSEcCtD
Glyburide—Anorexia—Irbesartan—type 2 diabetes mellitus	8.8e-06	0.000257	CcSEcCtD
Glyburide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.79e-06	0.000257	CcSEcCtD
Glyburide—Paraesthesia—Metformin—type 2 diabetes mellitus	8.79e-06	0.000257	CcSEcCtD
Glyburide—Confusional state—Losartan—type 2 diabetes mellitus	8.76e-06	0.000256	CcSEcCtD
Glyburide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.75e-06	0.000256	CcSEcCtD
Glyburide—Dyspnoea—Metformin—type 2 diabetes mellitus	8.72e-06	0.000255	CcSEcCtD
Glyburide—Oedema—Losartan—type 2 diabetes mellitus	8.69e-06	0.000254	CcSEcCtD
Glyburide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.68e-06	0.000254	CcSEcCtD
Glyburide—Hypotension—Irbesartan—type 2 diabetes mellitus	8.63e-06	0.000252	CcSEcCtD
Glyburide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.62e-06	0.000252	CcSEcCtD
Glyburide—Dyspepsia—Metformin—type 2 diabetes mellitus	8.61e-06	0.000252	CcSEcCtD
Glyburide—Tremor—Ramipril—type 2 diabetes mellitus	8.55e-06	0.00025	CcSEcCtD
Glyburide—Shock—Losartan—type 2 diabetes mellitus	8.55e-06	0.00025	CcSEcCtD
Glyburide—Urticaria—Valsartan—type 2 diabetes mellitus	8.54e-06	0.000249	CcSEcCtD
Glyburide—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.52e-06	0.000249	CcSEcCtD
Glyburide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.51e-06	0.000249	CcSEcCtD
Glyburide—Decreased appetite—Metformin—type 2 diabetes mellitus	8.5e-06	0.000249	CcSEcCtD
Glyburide—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.49e-06	0.000248	CcSEcCtD
Glyburide—Nausea—Bromocriptine—type 2 diabetes mellitus	8.46e-06	0.000247	CcSEcCtD
Glyburide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.45e-06	0.000247	CcSEcCtD
Glyburide—Urticaria—Orlistat—type 2 diabetes mellitus	8.43e-06	0.000246	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.41e-06	0.000246	CcSEcCtD
Glyburide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.4e-06	0.000245	CcSEcCtD
Glyburide—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.39e-06	0.000245	CcSEcCtD
Glyburide—Asthenia—Gliclazide—type 2 diabetes mellitus	8.39e-06	0.000245	CcSEcCtD
Glyburide—Angioedema—Ramipril—type 2 diabetes mellitus	8.34e-06	0.000244	CcSEcCtD
Glyburide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.29e-06	0.000242	CcSEcCtD
Glyburide—Anorexia—Losartan—type 2 diabetes mellitus	8.28e-06	0.000242	CcSEcCtD
Glyburide—Pruritus—Gliclazide—type 2 diabetes mellitus	8.27e-06	0.000242	CcSEcCtD
Glyburide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.23e-06	0.000241	CcSEcCtD
Glyburide—Leukopenia—Ramipril—type 2 diabetes mellitus	8.17e-06	0.000239	CcSEcCtD
Glyburide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.13e-06	0.000237	CcSEcCtD
Glyburide—Hypotension—Losartan—type 2 diabetes mellitus	8.12e-06	0.000237	CcSEcCtD
Glyburide—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.06e-06	0.000236	CcSEcCtD
Glyburide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.03e-06	0.000235	CcSEcCtD
Glyburide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8e-06	0.000234	CcSEcCtD
Glyburide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8e-06	0.000234	CcSEcCtD
Glyburide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.97e-06	0.000233	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.92e-06	0.000231	CcSEcCtD
Glyburide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.92e-06	0.000231	CcSEcCtD
Glyburide—Convulsion—Ramipril—type 2 diabetes mellitus	7.91e-06	0.000231	CcSEcCtD
Glyburide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.82e-06	0.000229	CcSEcCtD
Glyburide—Paraesthesia—Losartan—type 2 diabetes mellitus	7.8e-06	0.000228	CcSEcCtD
Glyburide—Gliclazide—ALB—type 2 diabetes mellitus	7.79e-06	0.00803	CrCbGaD
Glyburide—Urticaria—Metformin—type 2 diabetes mellitus	7.77e-06	0.000227	CcSEcCtD
Glyburide—Myalgia—Ramipril—type 2 diabetes mellitus	7.77e-06	0.000227	CcSEcCtD
Glyburide—Arthralgia—Ramipril—type 2 diabetes mellitus	7.77e-06	0.000227	CcSEcCtD
Glyburide—Dyspnoea—Losartan—type 2 diabetes mellitus	7.75e-06	0.000226	CcSEcCtD
Glyburide—Abdominal pain—Metformin—type 2 diabetes mellitus	7.73e-06	0.000226	CcSEcCtD
Glyburide—Asthenia—Valsartan—type 2 diabetes mellitus	7.71e-06	0.000225	CcSEcCtD
Glyburide—Dyspepsia—Losartan—type 2 diabetes mellitus	7.65e-06	0.000223	CcSEcCtD
Glyburide—Asthenia—Orlistat—type 2 diabetes mellitus	7.62e-06	0.000223	CcSEcCtD
Glyburide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.61e-06	0.000222	CcSEcCtD
Glyburide—Pruritus—Valsartan—type 2 diabetes mellitus	7.6e-06	0.000222	CcSEcCtD
Glyburide—Decreased appetite—Losartan—type 2 diabetes mellitus	7.55e-06	0.000221	CcSEcCtD
Glyburide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.55e-06	0.000221	CcSEcCtD
Glyburide—Confusional state—Ramipril—type 2 diabetes mellitus	7.51e-06	0.00022	CcSEcCtD
Glyburide—Pruritus—Orlistat—type 2 diabetes mellitus	7.51e-06	0.000219	CcSEcCtD
Glyburide—Oedema—Ramipril—type 2 diabetes mellitus	7.45e-06	0.000218	CcSEcCtD
Glyburide—Vomiting—Gliclazide—type 2 diabetes mellitus	7.44e-06	0.000217	CcSEcCtD
Glyburide—Rash—Gliclazide—type 2 diabetes mellitus	7.37e-06	0.000215	CcSEcCtD
Glyburide—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.37e-06	0.000215	CcSEcCtD
Glyburide—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.35e-06	0.000215	CcSEcCtD
Glyburide—Urticaria—Irbesartan—type 2 diabetes mellitus	7.33e-06	0.000214	CcSEcCtD
Glyburide—Shock—Ramipril—type 2 diabetes mellitus	7.33e-06	0.000214	CcSEcCtD
Glyburide—Headache—Gliclazide—type 2 diabetes mellitus	7.33e-06	0.000214	CcSEcCtD
Glyburide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.31e-06	0.000214	CcSEcCtD
Glyburide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.3e-06	0.000213	CcSEcCtD
Glyburide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.29e-06	0.000213	CcSEcCtD
Glyburide—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.26e-06	0.000212	CcSEcCtD
Glyburide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.2e-06	0.00021	CcSEcCtD
Glyburide—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.16e-06	0.000209	CcSEcCtD
Glyburide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.11e-06	0.000208	CcSEcCtD
Glyburide—Anorexia—Ramipril—type 2 diabetes mellitus	7.1e-06	0.000208	CcSEcCtD
Glyburide—Asthenia—Metformin—type 2 diabetes mellitus	7.02e-06	0.000205	CcSEcCtD
Glyburide—Bezafibrate—CYP3A4—type 2 diabetes mellitus	7.01e-06	0.00722	CrCbGaD
Glyburide—Hypotension—Ramipril—type 2 diabetes mellitus	6.96e-06	0.000203	CcSEcCtD
Glyburide—Nausea—Gliclazide—type 2 diabetes mellitus	6.95e-06	0.000203	CcSEcCtD
Glyburide—Pruritus—Metformin—type 2 diabetes mellitus	6.92e-06	0.000202	CcSEcCtD
Glyburide—Urticaria—Losartan—type 2 diabetes mellitus	6.9e-06	0.000202	CcSEcCtD
Glyburide—Abdominal pain—Losartan—type 2 diabetes mellitus	6.87e-06	0.000201	CcSEcCtD
Glyburide—Vomiting—Valsartan—type 2 diabetes mellitus	6.83e-06	0.0002	CcSEcCtD
Glyburide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.8e-06	0.000199	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.79e-06	0.000198	CcSEcCtD
Glyburide—Rash—Valsartan—type 2 diabetes mellitus	6.77e-06	0.000198	CcSEcCtD
Glyburide—Dermatitis—Valsartan—type 2 diabetes mellitus	6.77e-06	0.000198	CcSEcCtD
Glyburide—Vomiting—Orlistat—type 2 diabetes mellitus	6.75e-06	0.000197	CcSEcCtD
Glyburide—Headache—Valsartan—type 2 diabetes mellitus	6.73e-06	0.000197	CcSEcCtD
Glyburide—Diarrhoea—Metformin—type 2 diabetes mellitus	6.69e-06	0.000196	CcSEcCtD
Glyburide—Rash—Orlistat—type 2 diabetes mellitus	6.69e-06	0.000196	CcSEcCtD
Glyburide—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.69e-06	0.000195	CcSEcCtD
Glyburide—Dermatitis—Orlistat—type 2 diabetes mellitus	6.69e-06	0.000195	CcSEcCtD
Glyburide—Headache—Orlistat—type 2 diabetes mellitus	6.65e-06	0.000194	CcSEcCtD
Glyburide—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.64e-06	0.000194	CcSEcCtD
Glyburide—Asthenia—Irbesartan—type 2 diabetes mellitus	6.62e-06	0.000194	CcSEcCtD
Glyburide—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.56e-06	0.000192	CcSEcCtD
Glyburide—Pruritus—Irbesartan—type 2 diabetes mellitus	6.53e-06	0.000191	CcSEcCtD
Glyburide—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.48e-06	0.000189	CcSEcCtD
Glyburide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.43e-06	0.000188	CcSEcCtD
Glyburide—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.4e-06	0.000187	CcSEcCtD
Glyburide—Nausea—Valsartan—type 2 diabetes mellitus	6.38e-06	0.000186	CcSEcCtD
Glyburide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.32e-06	0.000185	CcSEcCtD
Glyburide—Nausea—Orlistat—type 2 diabetes mellitus	6.31e-06	0.000184	CcSEcCtD
Glyburide—Asthenia—Losartan—type 2 diabetes mellitus	6.23e-06	0.000182	CcSEcCtD
Glyburide—Vomiting—Metformin—type 2 diabetes mellitus	6.22e-06	0.000182	CcSEcCtD
Glyburide—Rash—Metformin—type 2 diabetes mellitus	6.17e-06	0.00018	CcSEcCtD
Glyburide—Dermatitis—Metformin—type 2 diabetes mellitus	6.16e-06	0.00018	CcSEcCtD
Glyburide—Pruritus—Losartan—type 2 diabetes mellitus	6.15e-06	0.00018	CcSEcCtD
Glyburide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.14e-06	0.000179	CcSEcCtD
Glyburide—Headache—Metformin—type 2 diabetes mellitus	6.13e-06	0.000179	CcSEcCtD
Glyburide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.09e-06	0.000178	CcSEcCtD
Glyburide—Diarrhoea—Losartan—type 2 diabetes mellitus	5.95e-06	0.000174	CcSEcCtD
Glyburide—Urticaria—Ramipril—type 2 diabetes mellitus	5.92e-06	0.000173	CcSEcCtD
Glyburide—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.89e-06	0.000172	CcSEcCtD
Glyburide—Vomiting—Irbesartan—type 2 diabetes mellitus	5.87e-06	0.000172	CcSEcCtD
Glyburide—Rash—Irbesartan—type 2 diabetes mellitus	5.82e-06	0.00017	CcSEcCtD
Glyburide—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.82e-06	0.00017	CcSEcCtD
Glyburide—Nausea—Metformin—type 2 diabetes mellitus	5.81e-06	0.00017	CcSEcCtD
Glyburide—Headache—Irbesartan—type 2 diabetes mellitus	5.78e-06	0.000169	CcSEcCtD
Glyburide—Vomiting—Losartan—type 2 diabetes mellitus	5.52e-06	0.000161	CcSEcCtD
Glyburide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.49e-06	0.00016	CcSEcCtD
Glyburide—Nausea—Irbesartan—type 2 diabetes mellitus	5.48e-06	0.00016	CcSEcCtD
Glyburide—Rash—Losartan—type 2 diabetes mellitus	5.48e-06	0.00016	CcSEcCtD
Glyburide—Dermatitis—Losartan—type 2 diabetes mellitus	5.47e-06	0.00016	CcSEcCtD
Glyburide—Headache—Losartan—type 2 diabetes mellitus	5.44e-06	0.000159	CcSEcCtD
Glyburide—Asthenia—Ramipril—type 2 diabetes mellitus	5.35e-06	0.000156	CcSEcCtD
Glyburide—Pruritus—Ramipril—type 2 diabetes mellitus	5.27e-06	0.000154	CcSEcCtD
Glyburide—Nausea—Losartan—type 2 diabetes mellitus	5.16e-06	0.000151	CcSEcCtD
Glyburide—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.1e-06	0.000149	CcSEcCtD
Glyburide—Vomiting—Ramipril—type 2 diabetes mellitus	4.74e-06	0.000138	CcSEcCtD
Glyburide—Rash—Ramipril—type 2 diabetes mellitus	4.7e-06	0.000137	CcSEcCtD
Glyburide—Dermatitis—Ramipril—type 2 diabetes mellitus	4.69e-06	0.000137	CcSEcCtD
Glyburide—Headache—Ramipril—type 2 diabetes mellitus	4.67e-06	0.000136	CcSEcCtD
Glyburide—Nausea—Ramipril—type 2 diabetes mellitus	4.43e-06	0.000129	CcSEcCtD
Glyburide—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	3.44e-07	1.63e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.43e-07	1.63e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	3.43e-07	1.63e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.42e-07	1.62e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.42e-07	1.62e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—type 2 diabetes mellitus	3.41e-07	1.62e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	3.41e-07	1.62e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	3.4e-07	1.61e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	3.4e-07	1.61e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	3.39e-07	1.61e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	3.39e-07	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.39e-07	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	3.39e-07	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	3.39e-07	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	3.39e-07	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	3.37e-07	1.6e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3.36e-07	1.6e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	3.36e-07	1.59e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	3.36e-07	1.59e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.34e-07	1.58e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	3.33e-07	1.58e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	3.33e-07	1.58e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	3.33e-07	1.58e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—INS—type 2 diabetes mellitus	3.33e-07	1.58e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	3.31e-07	1.57e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	3.31e-07	1.57e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	3.31e-07	1.57e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	3.31e-07	1.57e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	3.27e-07	1.55e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	3.27e-07	1.55e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	3.27e-07	1.55e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.26e-07	1.54e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	3.25e-07	1.54e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	3.25e-07	1.54e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	3.25e-07	1.54e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.25e-07	1.54e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.25e-07	1.54e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	3.24e-07	1.54e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GCG—type 2 diabetes mellitus	3.22e-07	1.53e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	3.22e-07	1.53e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.2e-07	1.52e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	3.19e-07	1.51e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	3.19e-07	1.51e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	3.17e-07	1.5e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	3.16e-07	1.5e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.11e-07	1.47e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.1e-07	1.47e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.1e-07	1.47e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	3.05e-07	1.45e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.05e-07	1.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.05e-07	1.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.04e-07	1.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.04e-07	1.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.04e-07	1.44e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.01e-07	1.43e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.01e-07	1.43e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	2.99e-07	1.42e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	2.98e-07	1.41e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.97e-07	1.41e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.97e-07	1.41e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	2.96e-07	1.4e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.94e-07	1.39e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.94e-07	1.39e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	2.94e-07	1.39e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—INS—type 2 diabetes mellitus	2.93e-07	1.39e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.92e-07	1.39e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	2.92e-07	1.38e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.92e-07	1.38e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.91e-07	1.38e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.91e-07	1.38e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—type 2 diabetes mellitus	2.89e-07	1.37e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.89e-07	1.37e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	2.89e-07	1.37e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	2.89e-07	1.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.87e-07	1.36e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2.82e-07	1.34e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.82e-07	1.34e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	2.82e-07	1.34e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.81e-07	1.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.81e-07	1.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.81e-07	1.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.81e-07	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.78e-07	1.32e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.77e-07	1.32e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GNB3—type 2 diabetes mellitus	2.77e-07	1.32e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	2.76e-07	1.31e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.75e-07	1.3e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.75e-07	1.3e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAT—type 2 diabetes mellitus	2.72e-07	1.29e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.7e-07	1.28e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	2.69e-07	1.27e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.68e-07	1.27e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	2.67e-07	1.27e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.67e-07	1.26e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOB—type 2 diabetes mellitus	2.65e-07	1.25e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.63e-07	1.25e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.63e-07	1.25e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	2.59e-07	1.23e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—type 2 diabetes mellitus	2.58e-07	1.22e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	2.57e-07	1.22e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	2.57e-07	1.22e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.57e-07	1.22e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—LPL—type 2 diabetes mellitus	2.53e-07	1.2e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.51e-07	1.19e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.49e-07	1.18e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.49e-07	1.18e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.48e-07	1.18e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	2.47e-07	1.17e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GPX1—type 2 diabetes mellitus	2.46e-07	1.17e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.45e-07	1.16e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.43e-07	1.15e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.43e-07	1.15e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.42e-07	1.15e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CD36—type 2 diabetes mellitus	2.4e-07	1.14e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.39e-07	1.13e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.37e-07	1.13e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	2.37e-07	1.12e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	2.35e-07	1.11e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.34e-07	1.11e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.32e-07	1.1e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.31e-07	1.1e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	2.31e-07	1.09e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.29e-07	1.09e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.29e-07	1.09e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	2.27e-07	1.08e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.27e-07	1.08e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.27e-07	1.08e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.27e-07	1.07e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—type 2 diabetes mellitus	2.26e-07	1.07e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—type 2 diabetes mellitus	2.26e-07	1.07e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.26e-07	1.07e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.25e-07	1.07e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.25e-07	1.07e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.23e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.23e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.23e-07	1.06e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARA—type 2 diabetes mellitus	2.23e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.23e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.22e-07	1.05e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.22e-07	1.05e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.21e-07	1.05e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.21e-07	1.05e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—type 2 diabetes mellitus	2.19e-07	1.04e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.18e-07	1.03e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.17e-07	1.03e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.17e-07	1.03e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AGT—type 2 diabetes mellitus	2.16e-07	1.02e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.16e-07	1.02e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.16e-07	1.02e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.15e-07	1.02e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.13e-07	1.01e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CALM1—type 2 diabetes mellitus	2.12e-07	1.01e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOE—type 2 diabetes mellitus	2.12e-07	1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.11e-07	9.99e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.1e-07	9.97e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOA1—type 2 diabetes mellitus	2.09e-07	9.92e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.08e-07	9.84e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.07e-07	9.8e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.04e-07	9.68e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.02e-07	9.6e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.02e-07	9.56e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2e-07	9.5e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2e-07	9.5e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2e-07	9.5e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2e-07	9.49e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.99e-07	9.45e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.97e-07	9.33e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.96e-07	9.31e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.95e-07	9.27e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.95e-07	9.24e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.94e-07	9.2e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.94e-07	9.2e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.91e-07	9.04e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.91e-07	9.04e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.9e-07	9.01e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.89e-07	8.98e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.88e-07	8.91e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.86e-07	8.83e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.86e-07	8.82e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.85e-07	8.79e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.84e-07	8.74e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.83e-07	8.69e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.83e-07	8.69e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.83e-07	8.66e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.81e-07	8.59e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.81e-07	8.59e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—INS—type 2 diabetes mellitus	1.81e-07	8.57e-06	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.8e-07	8.53e-06	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—type 2 diabetes mellitus	1.79e-07	8.47e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.77e-07	8.38e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.74e-07	8.24e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—type 2 diabetes mellitus	1.74e-07	8.24e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.74e-07	8.24e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.74e-07	8.24e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.73e-07	8.22e-06	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	1.71e-07	8.12e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.71e-07	8.12e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.66e-07	7.85e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.62e-07	7.7e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.62e-07	7.66e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—type 2 diabetes mellitus	1.6e-07	7.6e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.59e-07	7.52e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.59e-07	7.52e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.58e-07	7.51e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.51e-07	7.16e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.5e-07	7.1e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.5e-07	7.1e-06	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.49e-07	7.07e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.49e-07	7.07e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.49e-07	7.06e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.48e-07	7.02e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.47e-07	6.97e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.45e-07	6.89e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.45e-07	6.88e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.43e-07	6.77e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.42e-07	6.75e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.42e-07	6.75e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.39e-07	6.59e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.39e-07	6.59e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.39e-07	6.59e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.36e-07	6.46e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.36e-07	6.43e-06	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-07	6.37e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.33e-07	6.33e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.33e-07	6.31e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.3e-07	6.17e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-07	6.15e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-07	6.15e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.3e-07	6.14e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.28e-07	6.06e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.27e-07	6.03e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.23e-07	5.82e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.2e-07	5.71e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-07	5.63e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-07	5.6e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.17e-07	5.53e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.15e-07	5.44e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.14e-07	5.42e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.13e-07	5.36e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.95e-08	4.72e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.76e-08	4.63e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.95e-08	4.24e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.56e-08	4.06e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.56e-08	4.06e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.83e-08	3.71e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—type 2 diabetes mellitus	7.29e-08	3.46e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.54e-08	3.1e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.39e-08	3.03e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.97e-08	2.83e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.94e-08	1.87e-06	CbGpPWpGaD
